MarkWide Research

Sale!

In Vitro Toxicity Testing Market Analysis 2022-2030

Published Date: August, 2022
No of Pages: 153
Delivery Format: PDF+ Excel

$2,950.00

COVID-19 Impact on Global In In Vitro Toxicity Testing Market

Our research shows that the In Vitro Toxicity Testing Market is likely to grow at a CAGR of approximately 9.0%-11.0% over the next two years. The following factors play a major role in the growth of the global market, according to our analysis.

At a 10.3% CAGR, the In Vitro Toxicity Testing Market is expected to reach USD 14.9 Billion by 2025. It was USD 9.1 Billion in 2020. This market’s growth is mainly driven by opposition to animal testing and technological advances.

  • In Vitro Toxicity Testing Market have seen a rise in demand due to the need for quicker testing and more research in this field. FDA approved several in vitro diagnostic kits, including PCR testing panels and In vitro diagnostic assays.
  • In the U.S., COVID-19 is on the rise at an alarming rate. This has resulted in a decrease in patient visits to clinics and hospitals and a decline in the number of profiling studies being performed under normal circumstances. This will likely limit market growth to some extent.
  • The rapid spread of COVID-19 has put medical supplies and equipment shortages at risk. This is due to temporary lockdowns of manufacturing sites in affected areas or travel restrictions that have impacted shipments. Beyond transportation-related delays arising from travel restrictions and some driver shortage issues, COVID-19 hasn’t hugely impacted supplies of raw materials for in vitro toxicology technologies.
  • Normalization of the global economy will gradually increase diagnostic procedures or pipeline drugs. This will lead to market growth for the In Vitro Toxicity Testing Market.

In Vitro Toxicology Testing Market Dynamics

Driver: Opposition to animal testing

Animal testing can be a time-consuming and costly process that poses great safety risks to the animals. The risk of contracting the zoonotic disease by working with rodent or rabbit models is also increased. The European Union adopted legislation in 2004 that banned the testing of cosmetic ingredients on animals. The European Union would soon ban the testing of cosmetic ingredients on animals. Further amendments were made to this ban, which forbidding cosmetic products that have been tested on animals. Complex toxicological endpoints such as repeated-dose toxicology, reproductive toxicology, and toxicokinetics were exempted from this ban.

In Vitro Toxicity Testing Market

Get more information on this report : Download Free Sample Pages

Reluctance by regulatory authorities to look at alternative methods of proving safety or efficacy

Several industries have been focusing on non-animal-based methods of testing. In vivo testing is not always the best option for regulatory agencies. In vitro methods must be safer and more effective than animal methods under such circumstances. However, some countries are reluctant to use in vitro tests over in vivo, even though the assay is scientifically superior. Many U.S. regulatory agencies continue to use data from animal tests. Many agencies use in vivo methods to evaluate new toxicology test methods. New alternative methods can produce qualitatively different results than animal tests.

Opportunities: Increasing emphasis on drug discovery and personalized medicines using in vitro methods

The decline in productivity of the pharmaceutical industry has been evident over the years due to rising development costs and decreasing profitability of newly launched medical entities (NMEs). (Source: Tufts Center for the Study of Drug Development. The pharmaceutical industry faces the greatest challenge today: failure to develop promising drug candidates because of adverse effects in preclinical animal safety and clinical trials. Before new drugs go to clinical trials, it is important to develop techniques to predict and show efficacy in humans.

The challenge; the death of skilled professionals

IVT is a sophisticated method to study biological entities in a laboratory setting. This requires labor-intensive methods to conduct experiments. It also requires skilled professionals such as technicians and researchers to set up experiments, observe, collect results and analyze the data. Insufficient knowledge about the scientific principles behind the chosen technique can lead to several indirect and direct expenses. This could increase the workload of researchers and service providers. Highly-skilled personnel is required for method development, validation, operation, troubleshooting, and other activities.

Expect a strong CAGR for the organ toxicity segment.

The toxicity tests and endpoints market includes ADME, skin irritation, corrosion and sensitization, genotoxicity, cytotoxicity, ocular toxicity, organ toxicity, phototoxicity, dermal toxicity, and other toxicity tests & endpoints. Due to the increased focus on drug safety and the safety of consumer products, as well as the need to screen potential drug targets at an early stage of drug development, the organ toxicity segment will grow at the fastest CAGR in the In Vitro Toxicity Testing Market

In Vitro Toxicity Testing Market

Customize this report as per your requirement

In Vitro Toxicity Testing Market Report Scope and Segmentation
ATTRIBUTESDETAILS
ESTIMATED YEAR2022
BASE YEAR2021
FORECAST YEAR2030
HISTORICAL YEAR2019-2021
UNITValue (USD Million/Billion)
BY REGIONNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

Key Market Players of In Vitro Toxicity Testing Market

Thermo Fisher Scientific Inc., USA, Covance (U.S.), BioRad Laboratories, Inc., G.E. Healthcare, U.S., Eurofins Scientific S.E. (Luxembourg), Merck KGaA, Germany), Charles River Laboratories International, Inc., US, Catalent, Inc., US, Cyprotex (U.K.), SGS S.A.Switzerland), QIAGEN N.V. Germany), Promega Corporation, US, Gentronix Limited (U.K.), BioIVT, BioIVT (U.S.), BioIVT (U.S.), BioIVT (U.S.), BioIVT (U.S.), BioIVT (U.S.), M.B. Research Laboratories)

In Vitro Toxicology Testing Market, by Product & Service

By Product & Service

  • Consumables
  • Assays
    • Tests for Bacterial Toxicity
    • Enzyme Toxicity Tests
    • Cell-based Elisa & Western Blots
    • Receptor-binding assays
    • Tissue Culture Assays
    • Other Assays
  • Equipment
  • Software
  • Services

The market for In Vitro Toxicity Testing Market by Method

  • Cellular Assays
  • Biochemical Assays
  • In Silico Models
  • Ex Vivo Models

The market for In Vitro Toxicity Testing Market by Toxicity Endpoint & Test

  • Skin irritation, corrosion, and sensitization
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Phototoxicity Testing
  • Dermal Toxicity
  • Other toxicology endpoints and tests

By Industry, In Vitro Toxicity Testing Market

  • Covid Impact, By Industry
  • Pharmaceuticals & Biopharmaceuticals
  • Cosmetic & Household Products
  • Food
  • Chemicals
By Technology, In Vitro Toxicity Testing Market
  • Cell Culture Technologies
  • High-throughput Technology
  • Toxicogenomics

In Vitro Toxicity Testing Market

Interested in Any Specific Region or Country Level Data?

By Region, In Vitro Toxicity Testing Market
  • North America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of APAC
  • Latin America
  • Middle East & Africa

Table of Contents

1 INTRODUCTION (Page No. – 42)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 46)
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION & VALIDATION APPROACH
FIGURE 4 MARKET SIZE APPROACH
FIGURE 5 BOTTOM-UP APPROACH
2.3 DATA TRIANGULATION APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 54)
??? FIGURE 7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020 VS. 2025 (USD MILLION)
FIGURE 9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
FIGURE 10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020 VS. 2025 (USD MILLION)
FIGURE 11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020 VS. 2025 (USD MILLION)
FIGURE 12 GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET

4 PREMIUM INSIGHTS (Page No. – 59)
??? 4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
FIGURE 13 OPPOSITION TO ANIMAL TESTING IS A MAJOR FACTOR DRIVING MARKET GROWTH
4.2 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
FIGURE 14 CELLULAR ASSAYS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC IN VITRO TOXICOLOGY TESTING MARKET IN 2019
4.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 CHINA SHOWS THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
4.4 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION (2018?2025)
FIGURE 16 EUROPE WILL CONTINUE TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET IN 2025
4.5 IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 17 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. – 64)
??? 5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Opposition to animal testing
5.2.1.2 Technological advancements
5.2.1.3 R&D on early-stage toxicity detection
5.2.2 MARKET RESTRAINTS
5.2.2.1 Reluctance of regulatory authorities to consider alternative methods for proving safety and efficacy
5.2.2.2 Failure to establish the intricacies of in vivo conditions
5.2.2.3 Lack of in vitro models to study complex endpoints
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Increasing focus on drug discovery and personalized medicine using in vitro methods
5.2.3.2 Increasing number of toxicology databases
5.2.4 MARKET CHALLENGES
5.2.4.1 Dearth of skilled professionals

6 INDUSTRY INSIGHTS (Page No. – 71)
??? 6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
6.3 SUPPLY CHAIN ANALYSIS
FIGURE 19 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
6.4 REGULATORY COMMITTEE ACTIVITIES
6.4.1 MAJOR STAKEHOLDERS
6.4.2 KEY INFLUENCERS
6.5 COVID-19 IMPACT ON THE IN VITRO TOXICOLOGY MARKET
FIGURE 20 IMPACT OF COVID-19 ON IN VITRO TOXICOLOGY TESTING MARKET

7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE (Page No. – 76)
7.1 INTRODUCTION
7.2 COVID-19 IMPACT, BY PRODUCT & SERVICE
FIGURE 21 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
TABLE 1 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017?2019 (USD MILLION)
TABLE 2 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020?2025 (USD MILLION)
7.3 CONSUMABLES
7.3.1 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
TABLE 3 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 4 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
7.4 ASSAYS
TABLE 5 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,? 2017?2019 (USD MILLION)
TABLE 6 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020?2025 (USD MILLION)
TABLE 7 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 8 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
7.4.1 BACTERIAL TOXICITY ASSAYS
7.4.1.1 Bacterial assays dominate the market as they are the most widely adopted assay type across industries
TABLE 9 BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 10 BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
7.4.2 ENZYME TOXICITY ASSAYS
7.4.2.1 Enzyme toxicity assays are increasingly used for endocrine-disrupting studies?a key factor driving market growth
TABLE 11 ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 12 ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
7.4.3 CELL-BASED ELISA & WESTERN BLOTS
7.4.3.1 Cell-based assays are cost-effective, owing to which they are witnessing increasing adoption in drug discovery
TABLE 13 CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 14 CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
7.4.4 RECEPTOR-BINDING ASSAYS
7.4.4.1 Receptor-binding assays are well-suited for high-throughput formats, a key factor driving the adoption of these products
TABLE 15 RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 16 RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
7.4.5 TISSUE CULTURE ASSAYS
7.4.5.1 Tissue culture assays offer the advantage of mimicking in vivo tissue architecture
TABLE 17 TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 18 TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
7.4.6 OTHER ASSAYS
TABLE 19 OTHER ASSAYS MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 20 OTHER ASSAYS MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
7.5 EQUIPMENT
7.5.1 FULLY AUTOMATED EQUIPMENT IS WITNESSING GROWING ADOPTION IN RESEARCH
TABLE 21 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 22 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
7.6 SOFTWARE
7.6.1 SOFTWARE TOOLS ARE VITAL IN REDUCING ANALYSIS TIMES AND MANAGING LARGE AMOUNTS OF DATA GENERATED IN OPERATIONS
TABLE 23 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 24 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
7.7 SERVICES
7.7.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS
TABLE 25 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 26 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2020?2025 (USD MILLION)

8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST (Page No. – 99)
8.1 INTRODUCTION
FIGURE 22 ORGAN TOXICITY TESTING TO REGISTER THE HIGHEST GROWTH IN THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
TABLE 27 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017?2019 (USD MILLION)
TABLE 28 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020?2025 (USD MILLION)
8.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING
8.2.1 ADME TESTING TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
TABLE 29 ADME TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 30 ADME TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
8.3 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING
8.3.1 SKIN IRRITATION, CORROSION, AND SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN THE COSMETICS INDUSTRY
TABLE 31 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 32 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
8.4 GENOTOXICITY TESTING
8.4.1 MORE GENOTOXICITY TESTS ARE REVIEWED AND VALIDATED BY REGULATORY AUTHORITIES THAN ANY OTHER ENDPOINT? A KEY DRIVER FOR MARKET GROWTH
TABLE 33 GENOTOXICITY TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 34 GENOTOXICITY TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
8.5 CYTOTOXICITY TESTING
8.5.1 RISING NEED FOR BIOSAFETY IS LARGELY CONTRIBUTING TO THE GROWTH OF THE CYTOTOXICITY TESTING MARKET
TABLE 35 CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 36 CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
8.6 OCULAR TOXICITY TESTING
8.6.1 IN VITRO AND EX VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING
TABLE 37 OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 38 OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
8.7 ORGAN TOXICITY TESTING
8.7.1 HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY
TABLE 39 ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 40 ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
8.8 PHOTOTOXICITY TESTING
8.8.1 VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE THE PHOTOSAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS
TABLE 41 PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 42 PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
8.9 DERMAL TOXICITY TESTING
8.9.1 IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN THE COMING YEARS
TABLE 43 DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 44 DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
8.10 OTHER TOXICITY ENDPOINTS & TESTS
TABLE 45 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 46 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2020?2025 (USD MILLION)

9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY (Page No. – 118)
9.1 INTRODUCTION
FIGURE 23 TOXICOGENOMICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
TABLE 47 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017?2019 (USD MILLION)
TABLE 48 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020?2025 (USD MILLION)
9.2 CELL CULTURE TECHNOLOGIES
9.2.1 CELL- & TISSUE-BASED TECHNOLOGIES ARE THE MOST WIDELY ADOPTED IN IN VITRO TESTING
TABLE 49 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 50 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY, 2020?2025 (USD MILLION)
9.3 HIGH-THROUGHPUT TECHNOLOGIES
9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IS DRIVING MARKET GROWTH
TABLE 51 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 52 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2020?2025 (USD MILLION)
9.4 TOXICOGENOMICS
9.4.1 IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ARE ENHANCING THE STUDY OF GENE & PROTEIN ACTIVITY DURING TOXICITY ANALYSIS
TABLE 53 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 54 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2020?2025 (USD MILLION)

10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY (Page No. – 127)
???? 10.1 INTRODUCTION
FIGURE 24 PHARMACEUTICALS & BIOPHARMACEUTICALS TO COMMAND THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
TABLE 55 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017?2019 (USD MILLION)
TABLE 56 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020?2025 (USD MILLION)
10.2 COVID-19 IMPACT, BY INDUSTRY
10.3 PHARMACEUTICALS & BIOPHARMACEUTICALS
10.3.1 DRUG ATTRITION RATE IS LEADING TO THE HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN THE EARLY STAGES OF DRUG DEVELOPMENT
TABLE 57 PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 58 PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
10.4 COSMETICS & HOUSEHOLD PRODUCTS
10.4.1 BAN ON ANIMAL TESTING IS INCREASING THE ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING
TABLE 59 COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 60 COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
10.5 FOOD
10.5.1 INCREASING FOCUS ON FOOD SAFETY IS DRIVING MARKET GROWTH
TABLE 61 TYPES OF TOXICOLOGICAL TESTS IN THE FOOD INDUSTRY
TABLE 62 FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 63 FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
10.6 CHEMICALS
10.6.1 INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICAL TESTING IS PROPELLING THE MARKET
TABLE 64 CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 65 CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)

11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD (Page No. – 139)
???? 11.1 INTRODUCTION
FIGURE 25 IN SILICO MODELS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
TABLE 66 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017?2019 (USD MILLION)
TABLE 67 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020?2025 (USD MILLION)
11.2 CELLULAR ASSAYS
11.2.1 DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS
TABLE 68 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 69 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2020?2025 (USD MILLION)
11.3 BIOCHEMICAL ASSAYS
11.3.1 BIOCHEMICAL ASSAYS FIND WIDER APPLICATION IN THE PHARMACEUTICAL INDUSTRY AS COMPARED TO THE CHEMICAL AND FOOD INDUSTRIES
TABLE 70 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 71 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2020?2025 (USD MILLION)
11.4 IN SILICO MODELS
11.4.1 IN SILICO MODELS ARE EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
TABLE 72 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 73 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2020?2025 (USD MILLION)
11.5 EX-VIVO MODELS
11.5.1 EX-VIVO MODELS ARE WIDELY USED IN SKIN & EYE TOXICITY TESTING IN THE COSMETIC INDUSTRY
TABLE 74 IN VITRO TOXICOLOGY TESTING MARKET FOR EX-VIVO MODELS, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 75 IN VITRO TOXICOLOGY TESTING MARKET FOR EX-VIVO MODELS, BY COUNTRY, 2020?2025 (USD MILLION)

12 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION (Page No. – 149)
12.1 INTRODUCTION
12.2 COVID-19 IMPACT, BY REGION
FIGURE 26 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT (2019)
TABLE 76 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2017?2019 (USD MILLION)
TABLE 77 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2020?2025 (USD MILLION)
12.3 EUROPE
FIGURE 27 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
TABLE 78 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017?2019 (USD MILLION)
TABLE 79 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020?2025 (USD MILLION)
TABLE 80 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017?2019 (USD MILLION)
TABLE 81 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020?2025 (USD MILLION)
TABLE 82 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017?2019 (USD MILLION)
TABLE 83 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020?2025 (USD MILLION)
TABLE 84 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017?2019 (USD MILLION)
TABLE 85 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020?2025 (USD MILLION)
TABLE 86 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017?2019 (USD MILLION)
TABLE 87 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020?2025 (USD MILLION)
TABLE 88 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017?2019 (USD MILLION)
TABLE 89 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020?2025 (USD MILLION)
TABLE 90 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017?2024(USD MILLION)
TABLE 91 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020?2025 (USD MILLION)
12.3.1 GERMANY
12.3.1.1 Germany holds the largest share of the European market
TABLE 92 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017?2019 (USD MILLION)
TABLE 93 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020?2025 (USD MILLION)
TABLE 94 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017?2019 (USD MILLION)
TABLE 95 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020?2025 (USD MILLION)
TABLE 96 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017?2019 (USD MILLION)
TABLE 97 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020?2025 (USD MILLION)
TABLE 98 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017?2019 (USD MILLION)
TABLE 99 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020?2025 (USD MILLION)
TABLE 100 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017?2019 (USD MILLION)
TABLE 101 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020?2025 (USD MILLION)
TABLE 102 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017?2019 (USD MILLION)
TABLE 103 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020?2025 (USD MILLION)
12.3.2 UK
12.3.2.1 Rising awareness, growing R&D, and increasing collaborations are key indicators of market growth in the UK
TABLE 104 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017?2019 (USD MILLION)
TABLE 105 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020?2025 (USD MILLION)
TABLE 106 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017?2019 (USD MILLION)
TABLE 107 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020?2025 (USD MILLION)
TABLE 108 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017?2019 (USD MILLION)
TABLE 109 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020?2025 (USD MILLION)
TABLE 110 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017?2019 (USD MILLION)
TABLE 111 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020?2025 (USD MILLION)
TABLE 112 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017?2019 (USD MILLION)
TABLE 113 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020?2025 (USD MILLION)
TABLE 114 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017?2019 (USD MILLION)
TABLE 115 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020?2025 (USD MILLION)
12.3.3 FRANCE
12.3.3.1 Research initiatives supported by the government are aiding market growth in France
TABLE 116 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017?2019 (USD MILLION)
TABLE 117 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020?2025 (USD MILLION)
TABLE 118 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017?2019 (USD MILL

Segmentation

By Product & Service

  • Consumables
  • Assays
    • Tests for Bacterial Toxicity
    • Enzyme Toxicity Tests
    • Cell-based Elisa & Western Blots
    • Receptor-binding assays
    • Tissue Culture Assays
    • Other Assays
  • Equipment
  • Software
  • Services

By Method

  • Cellular Assays
  • Biochemical Assays
  • In Silico Models
  • Ex Vivo Models

By endpoint & Test

  • Skin irritation, corrosion, and sensitization
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Phototoxicity Testing
  • Dermal Toxicity
  • Other toxicology endpoints and tests

By Industry

  • Pharmaceuticals & Biopharmaceuticals
  • Cosmetic & Household Products
  • Food
  • Chemicals

By Technology

  • Cell Culture Technologies
  • High-throughput Technology
  • Toxicogenomics

Major Companies

Thermo Fisher Scientific Inc., USA, Covance (U.S.), BioRad Laboratories, Inc., G.E. Healthcare, U.S., Eurofins Scientific S.E. (Luxembourg), Merck KGaA, Germany), Charles River Laboratories International, Inc., US, Catalent, Inc., US, Cyprotex (U.K.), SGS S.A.Switzerland), QIAGEN N.V. Germany), Promega Corporation, US, Gentronix Limited (U.K.), BioIVT, BioIVT (U.S.), BioIVT (U.S.), BioIVT (U.S.), BioIVT (U.S.), BioIVT (U.S.), M.B. Research Laboratories)

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF